Research and Markets: Peptic Ulcer Therapeutics - Pipeline Assessment and Market Forecasts to 2018 - Business Wire

PPIs include omeprazole, lansoprazole, pantoprazole, Nexium (esomeprazole) and Aciphex (rabeprazole); and histamine blockers such as ranitidine, nizatidine, famotidine and cimetidine. Omeprazole is currently the most widely prescribed drug for peptic ...

Health Canada announces labelling update for Cipralex - News-Medical.Net

or are taking the heartburn drugs omeprazole or cimetidine which can increase the blood level of Cipralex. 20 mg per day is still the maximum recommended dose for most other patients.

Health Canada Updates Lexapro Label with Warning for Abnormal Heart Rhythm - Newsinferno.com

10 mg per day is the maximum recommended dose for patients who are 65 years of age or older, who have liver problems, or who are taking the heartburn drugs omeprazole or cimetidine, which can increase the blood level of Lexapro. The 20 mg per ...

PRESS RELEASE: Novartis drug pasireotide LAR -2- - finanzen.net

The use of Sandostatin LAR may increase the bioavailability of bromocriptine, impair intestinal absorption of cyclosporin and delay that of cimetidine. Drugs mainly metabolized by CYP3A4 and which have a low therapeutic index should be used with caution.

Novartis drug pasireotide LAR shows superior efficacy compared to SandostatinR LARR in Phase III trial of patients with acromegaly - Reuters

The use of Sandostatin LAR may increase the bioavailability of bromocriptine, impair intestinal absorption of cyclosporin and delay that of cimetidine. Drugs mainly metabolized by CYP3A4 and which have a low therapeutic index should be used with caution.

Drug Eruptions - Medscape News

Radiographic contrast material, alcohol, cytokines, opiates, cimetidine, quinine, hydralazine, atropine, vancomycin, and tubocurarine also may cause release of mast-cell mediators. Idiosyncratic reactions are unpredictable and not explained by ...